Search Ontology:
ChEBI

beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)]-alpha-D-Araf-(1->5)-alpha-D-ArafOCH2CH2NHCOCH2[OCH2CH2]6NH2

Term ID
CHEBI:149624
Synonyms
  • 20-amino-N-(2-{[beta-D-arabinofuranosyl-(1->2)-alpha-D-arabinofuranosyl-(1->3)-[beta-D-arabinofuranosyl-(1->2)-alpha-D-arabinofuranosyl-(1->5)]-alpha-D-arabinofuranosyl-(1->5)-alpha-D-arabinofuranosyl]oxy}ethyl)-3,6,9,12,15,18-hexaoxaicosan-1-amide
  • 23-amino-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosan-1-yl beta-D-arabinofuranosyl-(1->2)-alpha-D-arabinofuranosyl-(1->3)-[beta-D-arabinofuranosyl-(1->2)-alpha-D-arabinofuranosyl-(1->5)]-alpha-D-arabinofuranosyl-(1->5)-alpha-D-arabinofuranoside
  • 23-amino-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosan-1-yl beta-D-arabinosyl-(1->2)-alpha-D-arabinosyl-(1->3)-[beta-D-arabinosyl-(1->2)-alpha-D-arabinosyl-(1->5)]-alpha-D-arabinosyl-(1->5)-alpha-D-arabinoside
  • 23-amino-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosan-1-yl hexaarabinofuranoside
  • Ara6OCH2CH2NHCOCH2[OCH2CH2]6NH2
  • Arabeta1-2Araalpha1-3[Arabeta1-2Araalpha1-5]Aralpha1-5AraalphaOCH2CH2NHCOCH2[OCH2CH2]6NH2
  • Arabeta1->2Araalpha1->3[Arabeta1->2Araalpha1->5]Aralpha1->5AraalphaOCH2CH2NHCOCH2[OCH2CH2]6NH2
  • beta-D-Ara-(1->2)-alpha-D-Ara-(1->3)-[beta-D-Ara-(1->2)-alpha-D-Ara-(1->5)]-alpha-D-Ara-(1->5)-alpha-D-AraOCH2CH2NHCOCH2[OCH2CH2]6NH2
Definition
A synthetic glycoside that consists of the branched hexasaccharide beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)]-alpha-D-Araf-(1->5)-alpha-D-Araf having a 23-amino-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosan-1-yl moiety at the reducing-end anomeric centre.
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
has_functional_parent
Phenotype
Phenotype resulting from beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)]-alpha-D-Araf-(1->5)-alpha-D-ArafOCH2CH2NHCOCH2[OCH2CH2]6NH2
Phenotype where environments contain beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)]-alpha-D-Araf-(1->5)-alpha-D-ArafOCH2CH2NHCOCH2[OCH2CH2]6NH2
Phenotype modified by environments containing beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)]-alpha-D-Araf-(1->5)-alpha-D-ArafOCH2CH2NHCOCH2[OCH2CH2]6NH2
Human Disease Model